Search
01/06/2025
Factors associated with the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors after an episode of acute heart failure and prognostic impact
Llorens, P, Haro, A, Gil, V, Alquézar-Arbé, A, Jacob, J, Espinosa, B, de la Torre, MAG, Núñez, J, Rossello, X, Miró, O. Factors associated with the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors after an episode of acute heart failure and prognostic impact. REVISTA CLINICA ESPANOLA. 2025; 225(6)DOI:10.1016/j.rce.2025.502300. PMID:40316136. IF:1.700(Q2/4D).
01/06/2025
Use of Standardized Dosing Sheets in Pediatric Emergency Care: Experience in a Third-Level Hospital
Serralabós-Ferré, J, Castillo-Gomez, F, Sensarrich-Roset, M, Barceló-Carceller, I, Gonzalez-Rioja, X. Use of Standardized Dosing Sheets in Pediatric Emergency Care: Experience in a Third-Level Hospital. CLINICAL PEDIATRICS. 2025; 64(6)DOI:10.1177/00099228241301842. PMID:39660385. IF:0.700(Q4/8D).
01/06/2025
Anatomical and functional results of injectable plasma rich in growth factors as a treatment for poor prognosis macular holes
Caminal, M, Crespi, J, Rego, D, Oribio, C, Saladrigas, A, Conversa, S, Cobo, M, Díaz-Cascajosa, J, Vela, JI. Anatomical and functional results of injectable plasma rich in growth factors as a treatment for poor prognosis macular holes. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2025; 66(8)DOI:. PMID:. IF:4.700(Q1/1D).
01/06/2025
Baseline Characteristics and Treatment Patterns of Patients with Atopic Dermatitis Treated with Oral Systemic Therapies: An Interim Analysis of the AD-REAL Study
Augustin, M, Serra-Baldrich, E, Seneschal, J, Grond, S, Lampropoulou, A, Elrayes, M, Ogwu, S, de la Torre, I, Bewley, A, Pinter, A. Baseline Characteristics and Treatment Patterns of Patients with Atopic Dermatitis Treated with Oral Systemic Therapies: An Interim Analysis of the AD-REAL Study. ADVANCES IN THERAPY. 2025; 42(6)DOI:10.1007/s12325-025-03137-3. PMID:40192965. IF:4.000(Q1/3D).
01/06/2025
Cholinergic Pruritus as an Early Sign of Essential Thrombocythemia With Therapeutic Response to Ruxolitinib
Mateu-Arrom, L, Serra-Baldrich, E, Puig, L. Cholinergic Pruritus as an Early Sign of Essential Thrombocythemia With Therapeutic Response to Ruxolitinib. Actas Dermo-Sifiliograficas. 2025; 116(6)DOI:10.1016/j.ad.2023.09.035. PMID:39947585. IF:(Q/D).
01/06/2025
Current Challenges in Dermatology Residency Training
Ferrer, AL. Current Challenges in Dermatology Residency Training. Actas Dermo-Sifiliograficas. 2025; 116(6)DOI:10.1016/j.ad.2025.03.021. PMID:. IF:(Q/D).